Literature DB >> 25454992

Screening, prevention, and treatment of congenital cytomegalovirus.

Julie Johnson1, Brenna Anderson2.   

Abstract

Congenital cytomegalovirus (CMV) is a leading cause of permanent disability in children. The main source of maternal infection is from contact with young children. Primary maternal infection is diagnosed with demonstration of seroconversion or a positive CMV IgM in combination with a low-avidity CMV IgG. Fetal infection may be diagnosed with amniotic fluid polymerase chain reaction and culture. CMV-specific hyperimmune globulin has shown promise as a possible means to prevent congenital infection; large randomized trials are ongoing. To date, the only effective means of prevention is through reducing exposure to the virus. Rates of maternal infection may be reduced through education regarding sources of infection and improved hygiene.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CMV diagnosis; CMV hyperimmune globulin; CMV prevention; Congenital infection; Cytomegalovirus

Mesh:

Substances:

Year:  2014        PMID: 25454992     DOI: 10.1016/j.ogc.2014.08.005

Source DB:  PubMed          Journal:  Obstet Gynecol Clin North Am        ISSN: 0889-8545            Impact factor:   2.844


  4 in total

1.  The human cytomegalovirus lytic cycle is induced by 1,25-dihydroxyvitamin D3 in peripheral blood monocytes and in the THP-1 monocytic cell line.

Authors:  Shu-En Wu; William E Miller
Journal:  Virology       Date:  2015-05-15       Impact factor: 3.616

2.  Comparison of Presentation, Course, and Outcome of Congenital and Acquired Cytomegalovirus Infection in Twins.

Authors:  Veronica Mugarab Samedi; Christopher Skappak; Lindsay Jantzie; Cynthia Trevenen; Majeeda Kamaluddeen; Pauline Ekwalanga; Essa Hamdan Al Awad
Journal:  AJP Rep       Date:  2015-10-20

Review 3.  Maternal and fetal cytomegalovirus infection: diagnosis, management, and prevention.

Authors:  Robert F Pass; Ravit Arav-Boger
Journal:  F1000Res       Date:  2018-03-01

4.  Microsphere-based antibody assays for human parvovirus B19V, CMV and T. gondii.

Authors:  Yilin Wang; Lea Hedman; Maria F Perdomo; Amal Elfaitouri; Agnes Bölin-Wiener; Arun Kumar; Maija Lappalainen; Maria Söderlund-Venermo; Jonas Blomberg; Klaus Hedman
Journal:  BMC Infect Dis       Date:  2016-01-08       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.